OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
January 17, 2022
Deal helps expands software company’s labeling capabilities in clinical trial, med device and pharma spaces
Protagen, BioAnalytix and GeneWerk merger set to target biopharma, C> sectors
January 14, 2022
Tufts analysis uncovers various benefits to conducting decentralized clinical trials—including financial benefits
January 13, 2022
Will welcome seven temperature-controlled processing suites to accommodate various biologic drug needs
Partnership enhances CBM’s manufacturing capabilities in C> space
January 11, 2022
Syneos Health’s annual survey reveals the potential for shifts in the M&A space
January 10, 2022
Center’s 89,000 square-foot expansion expected to double its capacity
Strategic collaboration will feature Mammoth’s CRISPR know-how to design in vivo therapies
December 23, 2021
What are the key characteristics of hybrid direct-to-patient studies and supply chain structures that can make them a standard consideration for clinical trial adoption?
December 22, 2021
Emergency-use clearance of Pfizer drug a major milestone in the fight against the now-omicron-fueled virus in the US